SANA Stock Summary and Trading Ideas (Sana Biotechnology | NASDAQ:SANA)

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Sana Biotechnology trades on the NASDAQ stock market under the symbol SANA.

As of March 10, 2026, SANA stock price climbed to $3.41 with 232,438 million shares trading.

SANA has a beta of 2.33, meaning it tends to be more sensitive to market movements. SANA has a correlation of 0.15 to the broad based SPY ETF.

SANA has a market cap of $865.77 million. This is considered a Small Cap stock.

In the last 3 years, SANA traded as high as $12.00 and as low as $1.26.

The top ETF exchange traded funds that SANA belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWN.

SANA has outperformed the market in the last year with a return of +32.2%, while the SPY ETF gained +18.7%. However, in the most recent history, SANA shares have underperformed the stock market with its stock returning -21.6% in the last 3 month period and -16.2% for the last 2 week period, while SPY has returned -0.7% and -0.9%, respectively.

SANA support price is $3.14 and resistance is $3.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SANA shares will trade within this expected range on the day.